Clinical utility of targeted treatments in the management of epithelial ovarian cancer
Cheryl Twu,1 Ernest S Han21Department of Women’s Health, Arrowhead Regional Medical Center, Colton, CA, USA; 2Division of Gynecologic Oncology, City of Hope, Duarte, CA, USAAbstract: Epithelial ovarian cancer is typically found in its advanced stages, where a combination of surgical de...
Guardado en:
Autores principales: | Twu C, Han ES |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/174964cf40d8465eaa72fc7fe6ebb42c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier C
Publicado: (2012) -
Bevacizumab in the treatment of ovarian cancer
por: Ramez N Eskander, et al.
Publicado: (2011) -
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
por: Matthaiou EI, et al.
Publicado: (2014) -
Clinical utility of ramucirumab in advanced gastric cancer
por: Chan MMK, et al.
Publicado: (2015) -
STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/β-Catenin Signaling
por: Min Xie, et al.
Publicado: (2021)